NEW YORK, July 19, 2011 /PRNewswire/ --
- Key Staff Additions Diversify Senior Team
Rabin Martin, a leading global management consultancy working at the crossroads of health, announced today that Dr. Jeffrey L. Sturchio, President & Chief Executive Officer of the Global Health Council, will join the firm in September as Senior Partner. Sturchio will guide strategy, identify emerging issues and create new partnerships for the firm's corporate, multilateral and nonprofit clients.
"Improving the health of poor and disenfranchised communities around the world increases security and stability for us all," said Sturchio. "Collaboration among all sectors of society is a powerful way to find creative and sustainable solutions in global health. Rabin Martin, with its passionate staff and strong ties to prominent public and private clients, is well-positioned to design initiatives that lead to significant, lasting changes in public health."
Dr. Sturchio comes to Rabin Martin from a distinguished career in global health, corporate responsibility and public policy. He has led the Global Health Council since August 2009. The Council is the world's largest membership alliance of public health organizations and professionals dedicated to saving lives by improving health throughout the world. The Council coordinates efforts among its broad network to improve equity and outcomes in global health, working with international leaders, government agencies, multilateral organizations, non-governmental organizations, faith-based groups and private sector firms.
"In the nearly 20 years I've worked with Jeff, I've been impressed by his integrity and passion for improving the health of the world's poor," said Bill Martin, President of Rabin Martin. "His tireless drive and dedication are a testament to what can be achieved to halt the spread of disease through constant innovation in health solutions."
Dr. Sturchio joined the Global Health Council following nearly 20 years at Merck & Co., Inc., where he served both as Merck's Vice President for Corporate Responsibility and as President of The Merck Company Foundation. At Merck, Sturchio oversaw a portfolio of activities including the company's successful global health partnerships, such as the Merck MECTIZAN Donation Program to treat river blindness and lymphatic filariasis (a program credited with halting or nearly halting river blindness in parts of Latin America and West Africa), Merck's corporate philanthropy, the Merck Medical Outreach Program, global HIV/AIDS access programs (including Merck's participation in the UN/industry Accelerating Access Initiative and the African Comprehensive HIV/AIDS Partnerships in Botswana), the Merck Institute for Science Education, the Merck Childhood Asthma Network and corporate responsibility reporting. He also represented Merck on corporate responsibility, global health and philanthropy issues to the media, public officials, bilateral and multilateral organizations, NGOs and other external stakeholders.
Sturchio has also served as the Chairman of the Corporate Council on Africa, and currently is a Visiting Scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University and a member of the Global Agenda Council on Health of the World Economic Forum. He is also a member of the Council on Foreign Relations and a Fellow of the American Association for the Advancement of Science.
Dr. Sturchio's appointment follows other recent management additions at Rabin Martin, including:
- David Golub, Executive Vice President: Golub provided nearly 20 years of counsel to the private and public sectors, including eight years of service with the American Cancer Society, the largest private health organization in the world.
- Julie Becker, Senior Vice President: Becker developed and managed programs to improve the lives of vulnerable populations, leading HIV/AIDS and women's health initiatives for the International AIDS Vaccine Initiative, HealthRight International, EngenderHealth and the International Planned Parenthood Federation.
- Maria Schneider, Senior Vice President: Schneider worked closely with diverse organizations leading innovative health, social and public affairs programs and guiding CSR and strategic philanthropy at Edelman and the Pfizer Foundation and as an independent consultant, with major clients including the Business Roundtable, Lance Armstrong Foundation, UNICEF and Harvard School of Public Health.
"With Jeff and other recent additions to an already strong and diverse group, the depth of the firm's senior counseling team is unmatched in the field," said Steve Rabin, CEO of Rabin Martin.
About Rabin Martin
Rabin Martin is a leading public health management consulting firm specializing in programs both global and domestic. Rabin Martin has been a driving force behind numerous high profile global health programs, including the United Nations Foundation's Every Woman, Every Child initiative to raise global commitments for women and children's health; strategic planning for NGOs, foundations and universities in several countries; and global corporate reputation, policy, access to medicines and community relations programs for Fortune 100 companies, including Johnson & Johnson and Merck & Co., Inc. Rabin Martin continues to grow its staff, under the management of Steve Rabin, Chief Executive Officer, and Bill Martin, President.
Steve Rabin established Rabin Strategic Partners -- now Rabin Martin -- in 2002 to serve clients advancing public health goals. Steve has been on the faculty of the Columbia University School of Public Health and was a visiting fellow at the Harvard University School of Public Health. Prior to that he served as President of Ogilvy Public Affairs, head of the Washington, DC office of Porter Novelli and served as the Senior Vice President for Public Affairs at the Henry J. Kaiser Family Foundation.
Since joining the firm in 2009, Bill Martin has made substantial contributions to its success, helping grow the firm to more than 30 professionals. Before joining Rabin Martin, Bill served as President of Global Health at Cohn & Wolfe and GCI Health and was the senior communications and investor relations officer at two biotech companies.
For more information, please visit http://www.rabinmartin.com.
SOURCE Rabin Martin